Triazolam Tablet
Product Images NDC 50742-646

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Triazolam (NDC 50742-646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image01

NDC 50742-646-01 is the label of a bottle of Triazolam Tablets, USP with a strength of 0.25 mg. The prescribed drug comes in a bottle of 100 tablets and should be stored at a temperature of 20°C to 25°C. A pharmacist must dispense a medication guide to each patient. More information can be found in the accompanying prescribing information. It also provides a website to print Medication Guides.*

FDA Label Image

Image02

This is a medication label for Triazolam tablets, USP with 0.25mg strength. The medication guide is required to be given to each patient by the pharmacist. Dosage and usage information is provided in the accompanying prescribing information. The medication should be stored at a controlled room temperature of 20° to 25°C. A link to print medication guides is provided on www.ingenus.com/medguide/triazolam- tablets.pdf.*

FDA Label Image

Image03

This is a medication called Triazolam USP used as a treatment for insomnia. Each tablet contains 0.125 mg of Triazolam. Dosage and usage instructions are available in the accompanying USP prescribing information. The medication should be stored at room temperature between 20° to 25°C. Pharmacists are advised to dispense a medication guide to each patient. For more details, refer to the Medication Guides on the manufacturer's website.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.